Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02557672 · ClinicalTrials.gov registry record · Phase 4
PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
A Phase 4 study of Bleeding and Blood Loss, Surgical, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT02557672 is a Phase 4 study of Bleeding and Blood Loss, Surgical that has completed, run by Mayo Clinic. The registered enrollment target is 106 participants, below the 1,480-participant average among 23 other Bleeding trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02557672, a Phase 4 study of Bleeding and Blood Loss, Surgical, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be the first prospective randomized controlled clinical trial directly comparing Prothrombin Complex Concentrate (PCC) Compared to Fresh Frozen Plasma (FFP) for post cardiopulmonary bypass microvascular bleeding and factor-mediated coagulopathy. Is there a difference in bleeding and transfusion requirements in patients received PCC versus FFP?
Conditions Studied
Interventions
- DRUG Prothrombin complex concentrate (Human)
- BIOLOGICAL Fresh frozen plasma (FFP)
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2016-08 |
| Est. Completion | 2022-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02557672
The ClinicalTrials.gov registry entry for NCT02557672 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,480-participant average among 23 other Bleeding trials with a reported enrollment target (93% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Bleeding appearing as the primary indexed condition, and to 2 interventions - of which Prothrombin complex concentrate (Human) is the first listed.
NCT02557672 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02557672 about?
NCT02557672 is a clinical study titled "PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding". This will be the first prospective randomized controlled clinical trial directly comparing Prothrombin Complex Concentrate (PCC) Compared to Fresh Frozen Plasma (FFP) for post cardiopulmonary bypass microvascular bleeding and factor-mediated coagulopathy. Is there a difference in bleeding and transf...
What is the current status of trial NCT02557672?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2016-08. Estimated completion is 2022-01.
What conditions does trial NCT02557672 study?
This clinical trial studies the following conditions: Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures, Prothrombin Complex Concentrates, Fresh Frozen Plasma.
What interventions are being tested in trial NCT02557672?
The interventions under investigation include: Prothrombin complex concentrate (Human) (DRUG), Fresh frozen plasma (FFP) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02557672?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02557672 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RECRUITING · Phase 4
-
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
COMPLETED · Phase 4
-
Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen to Expedite Product Availability in Perioperative Bleeding
COMPLETED · Phase 4
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
RECRUITING
-
Quantra Point-of-Care Hemostasis Monitoring
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.